Article Details

SpliSense Presents Preclinical Data for SPL23-ASO, mRNA-Altering Drug Candidate for the ...

Retrieved on: 2021-06-11 09:00:00

Tags for this article:

Click the tags to see associated articles and topics

SpliSense Presents Preclinical Data for SPL23-ASO, mRNA-Altering Drug Candidate for the .... View article details on HISWAI: https://www.prnewswire.com/il/news-releases/splisense-presents-preclinical-data-for-spl23-aso-mrna-altering-drug-candidate-for-the-treatment-of-cystic-fibrosis-at-the-european-cystic-fibrosis-conference-301310187.html

Excerpt

JERUSALEM, June 11, 2021 /PRNewswire/ -- SpliSense, a biopharmaceutical company developing transformative mRNA-altering therapies for cystic ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up